U
Ulf de Faire
Researcher at Memorial Hospital of Rhode Island
Publications - 2
Citations - 1173
Ulf de Faire is an academic researcher from Memorial Hospital of Rhode Island. The author has contributed to research in topics: Interleukin 6 & Minor allele frequency. The author has an hindex of 2, co-authored 2 publications receiving 1004 citations. Previous affiliations of Ulf de Faire include University of Cambridge.
Papers
More filters
Journal ArticleDOI
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar,Adam S. Butterworth,Daniel F. Freitag,John Gregson,Peter Willeit,Donal Gorman,Pei Gao,Danish Saleheen,Augusto Rendon,Christopher P. Nelson,Peter S. Braund,Alistair S. Hall,Daniel I. Chasman,Anne Tybjærg-Hansen,John C. Chambers,Emelia J. Benjamin,Paul W. Franks,Robert Clarke,Arthur A. M. Wilde,Mieke D. Trip,Maristella Steri,Jacqueline C. M. Witteman,Lu Qi,C. Ellen van der Schoot,Ulf de Faire,Jeanette Erdmann,Heather M. Stringham,Wolfgang Koenig,Daniel J. Rader,David Melzer,David Reich,Bruce M. Psaty,Marcus E. Kleber,Demosthenes B. Panagiotakos,Johann Willeit,Patrik Wennberg,Mark Woodward,Svetlana Adamovic,Eric B. Rimm,Tom W. Meade,Richard F. Gillum,Jonathan A. Shaffer,Albert Hofman,Altan Onat,Johan Sundström,S. Wassertheil-Smoller,Dan Mellström,John Gallacher,Mary Cushman,Russell P. Tracy,Jussi Kauhanen,Magnus Karlsson,Jukka T. Salonen,Lars Wilhelmsen,Philippe Amouyel,Bernard Cantin,Lyle G. Best,Yoav Ben-Shlomo,JoAnn E. Manson,George Davey-Smith,Paul I.W. de Bakker,Christopher J. O'Donnell,James F. Wilson,Anthony G. Wilson,Themistocles L. Assimes,John-Olov Jansson,Claes Ohlsson,Åsa Tivesten,Östen Ljunggren,Muredach P. Reilly,Anders Hamsten,Erik Ingelsson,François Cambien,Joseph Hung,G. Neil Thomas,Michael Boehnke,Heribert Schunkert,Folkert W. Asselbergs,John J.P. Kastelein,Vilmundur Gudnason,Veikko Salomaa,Tamara B. Harris,Jaspal S. Kooner,Kristine H. Allin,Kristine H. Allin,Børge G. Nordestgaard,Jemma C. Hopewell,Alison H. Goodall,Paul M. Ridker,Hilma Holm,Hugh Watkins,Willem H. Ouwehand,Nilesh J. Samani,Stephen Kaptoge,Emanuele Di Angelantonio,Olivier Harari,John Danesh +96 more
TL;DR: In this article, a functional genetic variant known to affect IL6R signalling was studied to assess whether this pathway is causally relevant to coronary heart disease, and Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking.
Journal ArticleDOI
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.
Daniel I. Swerdlow,David Preiss,Karoline Kuchenbaecker,Michael V. Holmes,Jorgen Engmann,Tina Shah,Reecha Sofat,Stefan Stender,Paul C. D. Johnson,Robert A. Scott,Maarten Leusink,Niek Verweij,Stephen J. Sharp,Yiran Guo,Claudia Giambartolomei,Christina Chung,Anne Peasey,Antoinette Amuzu,KaWah Li,Jutta Palmen,Philip N. Howard,Jackie A. Cooper,Fotios Drenos,Yun Li,Gordon D.O. Lowe,John Gallacher,Marlene C. W. Stewart,Ioanna Tzoulaki,Sarah G. Buxbaum,Daphne L. van der A,Nita G. Forouhi,N. Charlotte Onland-Moret,Yvonne T. van der Schouw,Renate B. Schnabel,Jaroslav A. Hubacek,Ruzena Kubinova,Migle Baceviciene,Abdonas Tamosiunas,Andrzej Pajak,Romanvan Topor-Madry,Urszula Stepaniak,Sofia Malyutina,Damiano Baldassarre,Bengt Sennblad,Elena Tremoli,Ulf de Faire,Fabrizio Veglia,Ian Ford,J. Wouter Jukema,Rudi G. J. Westendorp,Gert J. de Borst,Pim A. de Jong,Ale Algra,Wilko Spiering,Anke H. Maitland-van der Zee,Olaf H. Klungel,Anthonius de Boer,Pieter A. Doevendans,Charles B. Eaton,Jennifer G. Robinson,David Duggan,John Kjekshus,John R. Downs,Antonio M. Gotto,Anthony C Keech,Roberto Marchioli,Gianni Tognoni,Peter S. Sever,Neil R Poulter,David D. Waters,Terje R. Pedersen,Pierre Amarenco,Haruo Nakamura,John J.V. McMurray,James Lewsey,Daniel I. Chasman,Paul M. Ridker,Aldo P. Maggioni,Luigi Tavazzi,Kausik K. Ray,Sreenivasa Rao Kondapally Seshasai,JoAnn E. Manson,Jackie F. Price,Peter H. Whincup,Richard W Morris,Debbie A Lawlor,George Davey Smith,Yoav Ben-Shlomo,Pamela J. Schreiner,Myriam Fornage,David S. Siscovick,Mary Cushman,Meena Kumari,Nicholas J. Wareham,W M Monique Verschuren,Susan Redline,Sanjay R. Patel,John C. Whittaker,Anders Hamsten,Joseph A.C. Delaney,Caroline Dale,Tom R. Gaunt,Andrew Wong,Diana Kuh,Rebecca Hardy,Sekar Kathiresan,Berta Almoguera Castillo,Pim van der Harst,Eric J. Brunner,Anne Tybjærg-Hansen,Michael Marmot,Ronald M. Krauss,Michael Y. Tsai,Josef Coresh,Ron C. Hoogeveen,Bruce M. Psaty,Leslie A. Lange,Hakon Hakonarson,Frank Dudbridge,Steve E. Humphries,Philippa J. Talmud,Mika Kivimäki,Nicholas J. Timpson,Claudia Langenberg,Folkert W. Asselbergs,Mikhail Voevoda,Martin Bobak,Hynek Pikhart,James G. Wilson,Alexander P. Reiner,Brendan J. Keating,Aroon D. Hingorani,Naveed Sattar +132 more
TL;DR: The increased risk of type 2 diabetes noted with statins is at least partially explained by HMGCR inhibition.